Lung Ultrasound Spectroscopy Applied to the Differential Diagnosis of Pulmonary Diseases: An In Vivo Multicenter Clinical Study

Lung ultrasound (LUS) is an important imaging modality to assess the state of the lung surface. However, current LUS approaches are based on subjective interpretation of imaging artifacts, which results in poor specificity as quantitative evaluation lacks. The latter could be improved by adopting LUS spectroscopy of vertical artifacts. Indeed, parameterizing these artifacts with native frequency, bandwidth, and total intensity ( ${I} {_{\text {TOT}}}$ ) already showed potentials in differentiating pulmonary fibrosis (PF). In this study, we acquired radio frequency (RF) data from 114 patients. These data (representing the largest LUS RF dataset worldwide) were acquired by utilizing a multifrequency approach, implemented with an ULtrasound Advanced Open Platform (ULA-OP). Convex (CA631) and linear (LA533) probes (Esaote, Florence, Italy) were utilized to acquire RF data at three (2, 3, and 4 MHz), and four (3, 4, 5, and 6 MHz) imaging frequencies. A multifrequency analysis was conducted on vertical artifacts detected in patients having cardiogenic pulmonary edema (CPE), pneumonia, or PF. These artifacts were characterized by the three abovementioned parameters, and their mean values were used to project each patient into a feature space having up to three dimensions. Binary classifiers were used to evaluate the performance of these three mean features in differentiating patients affected by CPE, pneumonia, and PF. Acquisitions of multifrequency data performed with linear probe lead to accuracies up to 85.43% in the differential diagnosis of these diseases (convex probes’ maximum accuracy was 74.51%). Moreover, the results showed high potentials of mean ${I} {_{\text {TOT}}}$ (by itself or combined with other features) in improving LUS specificity.